A review of drugs that contribute to bleeding risk in general dental practice

• Published in: Australian dental journal Vol. 65; no. 2; pp. 118 - 130
• Main Authors: Teoh, L, Moses, G, McCullough, MJ
• Format: Journal Article
• Language: English
• Published: Australia 01-06-2020
• Subjects: Anticoagulant; antiplatelet; anti‐thrombotic; bleeding risk; Dentistry; bleeding risk; Anticoagulant; dentistry; antiplatelet; anti-thrombotic
• ISSN: 0045-0421; 1834-7819
• DOI: 10.1111/adj.12751

The risk of postoperative bleeding is a daily concern for many general dental practitioners. A thorough medical and medication history must be taken to consider all risk factors, particularly drugs, that contribute to bleeding risk. While the risk from drugs such as aspirin, warfarin and clopidogrel are well known, the extent to which new antiplatelet agents and direct oral anticoagulants affect bleeding risk is less well understood. In addition, there are drugs other than antithrombotics, such as antidepressants and complementary medicines that also impair haemostasis. The aim of this paper is to provide dentists with an updated overview of the drugs commonly encountered in general dental practice that can contribute to a patient’s postoperative bleeding risk.